Pharmacogenomics is the study of how genes influence a person's pharmacological response. This relatively new area combines pharmacology (drug science) and genomics (the study of genes and their functions) to create effective, safe therapies and doses that are personalized to a person's genetic makeup. Pharmacogenomics is a pre-requisite for tailored medicine. It also combines pharmacology and genomics to learn how heredity affects the human body's medication response (classically correlating gene expression or SNPs with drug efficacy). Pharmacogenomics is still in its preliminary stages. Its application is currently limited, but novel ways are being investigated in clinical trials.
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece